Core Viewpoint - Shenzhen Dingyang Technology Co., Ltd. announced its annual profit distribution plan for 2024, which includes a cash dividend of 0.51 RMB per share, totaling approximately 81.19 million RMB for all shareholders [1][5]. Distribution Plan - The profit distribution plan was approved at the annual shareholders' meeting held on May 22, 2025 [1]. - The total number of shares for the distribution is based on 159,200,019 shares, with a cash dividend of 0.51 RMB per share (including tax) [1]. Relevant Dates - The key dates for the distribution are as follows: - Record date - Ex-dividend date - Cash dividend payment date [1]. Implementation Method - Cash dividends for shareholders with unrestricted circulating shares will be distributed through China Securities Depository and Clearing Corporation Limited, Shanghai Branch [1]. - Shareholders who have completed designated transactions can receive their cash dividends on the payment date at their designated securities business department [1]. Taxation Policies - For individual shareholders holding unrestricted circulating shares: - Those holding shares for over 1 year are exempt from individual income tax, receiving a net cash dividend of 0.51 RMB per share [2]. - For those holding shares for 1 year or less, the company will not withhold individual income tax at the time of distribution, but tax will be calculated upon transfer of shares [2]. - For shareholders holding restricted circulating shares, tax will be calculated based on the holding period after the lifting of restrictions [3]. - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied, resulting in a net cash dividend of 0.459 RMB per share [4]. - For Hong Kong investors holding shares through the "Shanghai-Hong Kong Stock Connect," a 10% withholding tax will also apply, leading to a net cash dividend of 0.459 RMB per share [4]. - Other corporate shareholders will be responsible for their own tax declarations, receiving a pre-tax cash dividend of 0.51 RMB per share [5].

| 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/6/5 | 2025/6/6 | 2025/6/6 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 22 日的2024年年度股东大会审议通过。 证券代码：688112 证券简称：鼎阳科技 公告编号：2025-020 深圳市鼎阳科技股份有限公司2024年年度权益分派 实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 二、 分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本159,200,019股为基数，每股派发现 金红利0.51元（含税），共计派发现金红利81,192,009.69元（含税）。 是否涉及差异化分红送转：否 每股分配比例 每股现金红利0 ...

Group 1 - China Energy Construction won a major coal-fired power project with a bid amount of approximately 14.586 billion yuan, involving six 660 MW supercritical coal-fired generating units and supporting environmental facilities, with a total construction period of about 36.5 months [1] - Taiji Industry plans to repurchase company shares with a total amount not less than 1 billion yuan and not exceeding 1.2 billion yuan, with a maximum repurchase price of 10.38 yuan per share [1] - Youxun Technology won a project from State Grid with a bid amount of approximately 176 million yuan, accounting for 17.44% of the company's audited revenue for 2024 [2] Group 2 - Daili New Materials established an investment fund with a total subscribed capital of 163.3 million yuan, with Daili contributing 10 million yuan, accounting for 6.12% of the fund [4] - Wanyi Technology received a government subsidy of 2.3475 million yuan, which has been confirmed and classified according to relevant accounting standards [6] - Anke Biotech received a drug registration certificate for Acetate Atosiban Injection, which is used for treating preterm labor [7] Group 3 - Renfu Pharmaceutical received a drug registration certificate for Progesterone Soft Capsules, which are used to treat functional disorders caused by progesterone deficiency [9] - Linyang Energy is a recommended candidate for a major contract with State Grid, with a total expected bid amount of approximately 165 million yuan [11] - Hongtian Technology plans to invest 200 million to 300 million yuan to establish a wholly-owned subsidiary in Gansu Province [28] Group 4 - Hunan Xiang Electric received a total of 40 million yuan in government subsidies, which accounts for 16.07% of the company's audited net profit for 2024 [44] - Nengke Technology plans to repurchase shares with a total amount not less than 10 million yuan and not exceeding 20 million yuan, with a maximum repurchase price of 43.00 yuan per share [46] - Xiamen XGMA received 10 million yuan in historical debt repayment, which is expected to increase the company's net profit for 2025 by 3.186 million yuan [48]

证券代码：688112 证券简称：鼎阳科技 公告编号：2025-019 深圳市鼎阳科技股份有限公司 关于自愿披露公司发布新产品的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、新产品基本情况 SDS7000L 系列高端紧凑型高分辨率数字示波器最高带宽达 8 GHz，垂直分 辨率为 12-bit，四通道最大采样率均为 20 GSa/s，最高存储深度为 2 Gpts/ch， 集成了与公司高端台式机 SDS7000A 系列高分辨率数字示波器同等的信号处理 能力。该系列产品采用 2U 标准机架尺寸设计，精准适配机柜安装，支持多设 2025 年 5 月 27 日，深圳市鼎阳科技股份有限公司（以下简称"鼎阳科 技"、"公司"）正式公开发布最高带宽达 8 GHz、12-bit 的 SDS7000L 系列高端紧凑型高分辨率数字示波器。 SDS7000L 系列紧凑型高分辨率数字示波器集成了与公司高端台式机 SDS7000A 系列高分辨率数字示波器同等的信号处理能力，采用 2U 标 准机架尺寸设计，精准适配机柜安装 ...

金十数据5月27日讯，鼎阳科技公告，公司于2025年5月27日发布最高带宽达8GHz、12-bit的SDS7000L 系列高端紧凑型高分辨率数字示波器。该系列产品采用2U标准机架尺寸设计，精准适配机柜安装，支 持多设备密集部署，兼顾了机架部署的空间效率与专业测量的精度需求，可广泛应用于工业自动化、通 信、新能源等领域。本次发布的产品属于高端系列产品，进一步丰富了公司的产品矩阵和产品形态，拓 宽了公司产品的应用场景和使用范围，将有助于巩固和提升公司的综合竞争力。 鼎阳科技：发布最高带宽达8GHz新产品 ...

证券代码：688112 证券简称：鼎阳科技 公告编号：2025-018 深圳市鼎阳科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 05 月 22 日 （二） 股东会召开的地点：深圳市宝安区新安街道兴东社区安通达工业园 5 栋 1 层会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 49 | | --- | --- | | 普通股股东人数 | 49 | | 2、出席会议的股东所持有的表决权数量 | 115,322,803 | | 普通股股东所持有表决权数量 | 115,322,803 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比例 | 72.4389 | | （%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 72.4389 | ...

上海市锦天城（深圳）律师事务所 法律意见书 上海市锦天城（深圳）律师事务所 关于深圳市鼎阳科技股份有限公司 2024 年年度股东大会的 法律意见书 地址：深圳市福田中心区福华三路卓越世纪中心 1 号楼 21-23 层 电话：0755-82816698 传真：0755-82816898 上海市锦天城（深圳）律师事务所 法律意见书 上海市锦天城（深圳）律师事务所 关于深圳市鼎阳科技股份有限公司 2024 年年度股东大会的 法律意见书 致：深圳市鼎阳科技股份有限公司 上海市锦天城（深圳）律师事务所（以下简称"本所"）接受深圳市鼎阳科 技股份有限公司（以下简称"公司"）的委托，指派律师出席公司 2024 年年度 股东大会（以下简称"本次股东大会"），并根据《中华人民共和国公司法》（以 下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司股东大会规则》（以下简称"《股东大会规则》"）等法律、法规和 规范性文件以及现行有效的《深圳市鼎阳科技股份有限公司章程》（以下简称"《公 司章程》"）的相关规定，对本次股东大会相关法律事项进行见证并出具本法律 意见书。公司已向本所提供了本所律师为出具 ...

Group 1 - Lingyun Optics' actual controller promises not to reduce shareholdings for 12 months starting from July 7, 2025 [1] - Chengdi Xiangjiang's subsidiary signed a contract with China Mobile for a data center project worth 1.632 billion yuan, with a 92-day construction period starting April 30, 2025 [1] - Dingyang Technology launched a high-end arbitrary waveform generator with a maximum output frequency of 5 GHz, catering to communication, industrial, and research testing needs [2][3] Group 2 - Heng Rui Medicine completed a share repurchase plan, buying back 12.9051 million shares for 601 million yuan, representing 0.20% of total shares [4][5] - ST Xiangxue received approval for clinical trials of TAEST1901 injection for treating advanced gastric cancer [5] - Yuyue Medical's subsidiary received EU MDR certification for its AED product, valid until May 11, 2030 [6][7] Group 3 - HNA Holding reported a 10.33% year-on-year increase in passenger revenue kilometers for April [8] - Springhui Zhikong's subsidiary terminated its listing on the National Equities Exchange and Quotations [9] - Delin Hai's shareholder plans to reduce holdings by up to 3%, equating to 3.39 million shares [10] Group 4 - Weiye Co. announced that two shareholders plan to reduce their holdings by up to 2% [12] - Green Alliance Technology's major shareholder intends to reduce holdings by up to 3% [14] - Luzhou Development Group increased its stake in Luzhou Tianhua by 1.02%, acquiring 15.9557 million shares [16] Group 5 - Hualan Pharmaceutical's subsidiary plans to acquire a 42.82% stake in Sanjing Qianhe for 23.446 million yuan [17] - Ganfeng Lithium's directors and executives plan to invest 30.8 million yuan in Shenzhen Yichu [19] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project [20] Group 6 - Jinkai Biotechnology's Blue Zone Fund plans to reduce holdings by up to 3% [21] - Hangxin Technology's former controlling shareholder intends to reduce holdings by up to 3% [22] - Galaxy Magnet's director plans to reduce holdings by up to 0.79% [23] Group 7 - Zhuoyue Technology's controlling shareholder's shares will be auctioned due to judicial proceedings [24] - Xinwufeng is forming a joint venture with France's Coplison Group with a registered capital of 80 million yuan [25] - Zhongcheng Co. is planning to issue shares to acquire 100% of a clean energy company, leading to a temporary stock suspension [26][27]

证券代码：688112 证券简称：鼎阳科技 公告编号：2025-017 | 产品名称 | 产品型号 | 产品性能指标 | | --- | --- | --- | | | | 最高输出频率： 5 GHz | | | | 调制带宽：2 GHz | | 系列任 SDG8000A | SDG8002A | 最大采样率：12 GSa/s | | 意波形发生器 | SDG8004A | 最大通道数量：4 | | | | 垂直分辨率：16-bit | | | | 最大任意波形长度：4Gpts/Ch | 二、新产品对公司的影响 深圳市鼎阳科技股份有限公司 关于自愿披露公司发布新产品的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、新产品基本情况 SDG8000A 系列高端任意波形发生器最高输出频率达 5 GHz，最大调制带 宽可达 2GHz，具备最大 4 个模拟输出通道，且每通道存储深度最高达 4 Gpts， 拥有高频高精度、自由波形编辑以及全面的调制与协议支持能力。 该系列产品提供高速串行码型信号输出，支持复 ...

Group 1 - The core viewpoint of the news highlights the significant growth of Dingyang Technology, with a 93% year-on-year increase in revenue for Q1 2025, driven by a successful high-end development strategy [1] - Dingyang Technology's high-end product revenue share increased to 29%, up by 8.85 percentage points year-on-year, indicating a strong market position [1] - The company has implemented a "produce one generation, research one generation, reserve one generation" R&D strategy, continuously launching more competitive high-end products [1] Group 2 - The market sizes for spectrum analyzers, signal generators, and vector network analyzers are reported as $1.403 billion, $905 million, and $784 million respectively, with projected compound annual growth rates (CGR) of 6.80%, 5.89%, and 6.37% from 2022 to 2027 [1] - In 2024, Dingyang Technology's direct sales revenue is projected to be 75.67 million yuan, accounting for 15.21% of total revenue, reflecting a year-on-year increase of 1.69 percentage points [1]